Skip to main content
. 2016 Jun 15;12(2):1171–1177. doi: 10.3892/ol.2016.4735

Table I.

Clinical features of the 12 patients with lung adenocarcinoma.

Patient no. Gender Age (years) Histological type Tobacco smoking history pTNM stage Tumor grade EGFR mutation
  1 M 47 Adenocarcinoma Yes T2aN0M0 IB Exon 19 deletion
  2 F 82 Adenocarcinoma No T2aN0M0 IB Unknown
  3 F 41 Adenocarcinoma No T2aN1M1 IV Unknown
  4 F 50 Adenocarcinoma No T2aN0M0 IB Unknown
  5 F 47 Adenocarcinoma No T2aN0M0 IB Unknown
  6 F 69 Adenocarcinoma No T1aN2M0 IIIA Exon 19 deletion
  7 M 46 Adenocarcinoma No T2bN1M0 IIB Unknown
  8 F 73 Adenocarcinoma No T2aN1M0 IIA No mutation
  9 F 50 Adenocarcinoma No T1bN0M0 IA Unknown
10 F 51 Adenocarcinoma No T2bN3M0 IIIB No mutation
11 M 37 Adenocarcinoma No T1bN0M0 IA Unknown
12 M 43 Adenocarcinoma No T1bN2M0 IIIA Unknown

M, male; F, female; TNM, tumor-node-metastasis; EGFR, epidermal growth factor receptor.